Quantification of joint mobility limitation in adult type 1 diabetes

dc.contributor.authorPhatak, Sanaten_US
dc.contributor.authorCHAKLADAR, SHREYAen_US
dc.contributor.authorGOEL, PRANAY et al.en_US
dc.contributor.departmentDept. of Biologyen_US
dc.date.accessioned2024-02-12T11:50:10Z
dc.date.available2024-02-12T11:50:10Z
dc.date.issued2023-11en_US
dc.description.abstractAims: Diabetic cheiroarthropathies limit hand mobility due to fibrosis and could be markers of a global profibrotic trajectory. Heterogeneity in definitions and lack of a method to measure it complicate studying associations with organ involvement and treatment outcomes. We measured metacarpophalangeal (MCP) joint extension as a metric and describe magnetic resonance (MR) imaging determinants of MCP restriction.Methods: Adults with type 1 diabetes were screened for hand manifestations using a symptom questionnaire, clinical examination, and function [Duruoz hand index (DHI) and grip strength]. Patients were segregated by mean MCP extension (<20 degrees, 20 degrees-40 degrees, 40 degrees-60 degrees, and >60 degrees) for MR imaging (MRI) scanning. Patients in the four groups were compared using ANOVA for clinical features and MRI tissue measurements (tenosynovial, skin, and fascia thickness). We performed multiple linear regression for determinants of MCP extension.Results: Adults with type 1 diabetes were screened for hand manifestations using a symptom questionnaire, clinical examination, and function [Duruoz hand index (DHI) and grip strength]. Patients were segregated by mean MCP extension (<20 degrees, 20 degrees-40 degrees, 40 degrees-60 degrees, and >60 degrees) for MR imaging (MRI) scanning. Patients in the four groups were compared using ANOVA for clinical features and MRI tissue measurements (tenosynovial, skin, and fascia thickness). We performed multiple linear regression for determinants of MCP extension.Conclusion: Joint mobility limitation was quantified by restricted mean MCP extension and had structural correlates on MRI. These can serve as quantitative measures for future associative and interventional studiesen_US
dc.identifier.citationFrontiers in Endocrinology,14.en_US
dc.identifier.issn1664-2392en_US
dc.identifier.sourcetitleFrontiers in Endocrinologyen_US
dc.identifier.urihttps://doi.org/10.3389/fendo.2023.1238825
dc.identifier.urihttp://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/8496
dc.language.isoenen_US
dc.publication.originofpublisherForeignen_US
dc.publisherFrontiers Media S.A.en_US
dc.subjectMagnetic resonance imaging (MRI)en_US
dc.subjectOutcome measure (healthcare)en_US
dc.subjectTenosynovitisen_US
dc.subjectMetacarpophalangeal (MCP) jointen_US
dc.subjectLimited joint mobility (LJM)en_US
dc.subjectStiffnessen_US
dc.subject2023en_US
dc.titleQuantification of joint mobility limitation in adult type 1 diabetesen_US
dc.typeArticleen_US

Files

Collections